| Name | MYG1 exonuclease |
| Description | Enables 3'-5'-RNA exonuclease activity. Involved in mRNA processing; mitochondrial RNA metabolic process; and rRNA processing. Located in mitochondrion and nucleus. Is active in mitochondrial matrix; nucleolus; and nucleoplasm. [provided by Alliance of Genome Resources, Mar 2025] |
| Summary |
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nMYG1 (Melanocyte proliferating gene 1, also known as C12orf10 or Gamm1) is a highly conserved gene present in both simple and complex eukaryotes. Early studies predicted that its protein product contains a metal‐dependent protein hydrolase (UPF0160) domain, and initial work focused on elucidating its expression profile and subcellular localization, laying the groundwork for understanding its emerging biological roles."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "1"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nSubsequent investigations revealed that MYG1 functions as a ubiquitous nucleo‐mitochondrial protein involved in early developmental processes as well as adult stress and illness responses. Genetic analyses identified both promoter and coding polymorphisms that affect MYG1 regulation; notably, these variants have been linked to pigmentary disorders, with elevated MYG1 expression and specific polymorphisms being associated with vitiligo, suggesting an involvement in melanocyte biology and immune modulation."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "2"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nFurther functional analyses have established MYG1 as a 3′–5′ RNA exonuclease that plays a critical role in organellar RNA processing. Dually localized in the nucleolus and mitochondrial matrix, MYG1 facilitates the maturation of pre‐ribosomal RNA—thereby influencing ribosome assembly and cytoplasmic translation—and processes the 3′ termini of mitochondrial ribosomal and messenger RNAs, ultimately modulating mitochondrial protein synthesis."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "4"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nMore recent studies have also implicated MYG1 in cancer metabolism. In colorectal cancer, upregulated MYG1 promotes a metabolic shift toward glycolysis independent of its exonuclease activity by recruiting protein complexes that enhance PKM2 phosphorylation and stability. This activity is complemented by mitochondrial functions that simultaneously inhibit oxidative phosphorylation and block apoptotic signaling, collectively contributing to tumor progression and highlighting MYG1 as a potential therapeutic target in cancers characterized by metabolic dysregulation."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "5"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Mari-Anne Philips, Jonas Vikeså, Hendrik Luuk, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Characterization of MYG1 gene and protein: subcellular distribution and function."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biol Cell (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1042/BC20080086"}], "href": "https://doi.org/10.1042/BC20080086"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19014353"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19014353"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Mari-Anne Philips, Külli Kingo, Maire Karelson, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Promoter polymorphism -119C/G in MYG1 (C12orf10) gene is related to vitiligo susceptibility and Arg4Gln affects mitochondrial entrance of Myg1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "BMC Med Genet (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/1471-2350-11-56"}], "href": "https://doi.org/10.1186/1471-2350-11-56"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20377893"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20377893"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Mitesh Dwivedi, Naresh C Laddha, Rasheedunnisa Begum "}, {"type": "b", "children": [{"type": "t", "text": "Correlation of increased MYG1 expression and its promoter polymorphism with disease progression and higher susceptibility in vitiligo patients."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Dermatol Sci (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.jdermsci.2013.04.026"}], "href": "https://doi.org/10.1016/j.jdermsci.2013.04.026"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23706493"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23706493"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Ritika Grover, Shaunak A Burse, Shambhavi Shankrit, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Myg1 exonuclease couples the nuclear and mitochondrial translational programs through RNA processing."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nucleic Acids Res (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1093/nar/gkz371"}], "href": "https://doi.org/10.1093/nar/gkz371"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31081026"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31081026"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Jianxiong Chen, Shiyu Duan, Yulu Wang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MYG1 drives glycolysis and colorectal cancer development through nuclear-mitochondrial collaboration."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Commun (2024)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41467-024-49221-0"}], "href": "https://doi.org/10.1038/s41467-024-49221-0"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "38862489"}], "href": "https://pubmed.ncbi.nlm.nih.gov/38862489"}]}]}]}
|
| NCBI Gene ID | 60314 |
| API | |
| Download Associations | |
| Predicted Functions |
![]() |
| Co-expressed Genes |
![]() |
| Expression in Tissues and Cell Lines |
![]() |
MYG1 has 1,369 functional associations with biological entities spanning 6 categories (chemical, disease, phenotype or trait, functional term, phrase or reference, cell line, cell type or tissue, gene, protein or microRNA, sequence feature) extracted from 26 datasets.
Click the + buttons to view associations for MYG1 from the datasets below.
If available, associations are ranked by standardized value
| Dataset | Summary | |
|---|---|---|
| Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of MYG1 gene relative to other tissue samples from the Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles dataset. | |
| Carcinogenome Chemical Perturbation Carcinogenicity Signatures | small molecule perturbations changing expression of MYG1 gene from the Carcinogenome Chemical Perturbation Carcinogenicity Signatures dataset. | |
| CCLE Cell Line Proteomics | Cell lines associated with MYG1 protein from the CCLE Cell Line Proteomics dataset. | |
| CellMarker Gene-Cell Type Associations | cell types associated with MYG1 gene from the CellMarker Gene-Cell Type Associations dataset. | |
| ChEA Transcription Factor Targets 2022 | transcription factors binding the promoter of MYG1 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets 2022 dataset. | |
| CM4AI KOLF21J CRISPRi Gene Perturbation Atlas | gene perturbations changing expression of MYG1 gene from the CM4AI KOLF21J CRISPRi Gene Perturbation Atlas dataset. | |
| DepMap CRISPR Gene Dependency | cell lines with fitness changed by MYG1 gene knockdown relative to other cell lines from the DepMap CRISPR Gene Dependency dataset. | |
| DisGeNET Gene-Disease Associations | diseases associated with MYG1 gene in GWAS and other genetic association datasets from the DisGeNET Gene-Disease Associations dataset. | |
| GO Biological Process Annotations 2025 | biological processes involving MYG1 gene from the curated GO Biological Process Annotations2025 dataset. | |
| GO Cellular Component Annotations 2023 | cellular components containing MYG1 protein from the curated GO Cellular Component Annotations 2023 dataset. | |
| GO Cellular Component Annotations 2025 | cellular components containing MYG1 protein from the curated GO Cellular Component Annotations 2025 dataset. | |
| GO Molecular Function Annotations 2025 | molecular functions performed by MYG1 gene from the curated GO Molecular Function Annotations 2025 dataset. | |
| GTEx eQTL 2025 | SNPs regulating expression of MYG1 gene from the GTEx eQTL 2025 dataset. | |
| GTEx Tissue Gene Expression Profiles 2023 | tissues with high or low expression of MYG1 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles 2023 dataset. | |
| GTEx Tissue-Specific Aging Signatures | tissue samples with high or low expression of MYG1 gene relative to other tissue samples from the GTEx Tissue-Specific Aging Signatures dataset. | |
| JASPAR Predicted Human Transcription Factor Targets 2025 | transcription factors regulating expression of MYG1 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Human Transcription Factor Targets dataset. | |
| JASPAR Predicted Mouse Transcription Factor Targets 2025 | transcription factors regulating expression of MYG1 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Mouse Transcription Factor Targets 2025 dataset. | |
| LINCS L1000 CMAP Chemical Perturbation Consensus Signatures | small molecule perturbations changing expression of MYG1 gene from the LINCS L1000 CMAP Chemical Perturbations Consensus Signatures dataset. | |
| LINCS L1000 CMAP CRISPR Knockout Consensus Signatures | gene perturbations changing expression of MYG1 gene from the LINCS L1000 CMAP CRISPR Knockout Consensus Signatures dataset. | |
| MGI Mouse Phenotype Associations 2023 | phenotypes of transgenic mice caused by MYG1 gene mutations from the MGI Mouse Phenotype Associations 2023 dataset. | |
| PFOCR Pathway Figure Associations 2024 | pathways involving MYG1 protein from the Wikipathways PFOCR 2024 dataset. | |
| Replogle et al., Cell, 2022 RPE1 Essential Perturb-seq Gene Perturbation Signatures | gene perturbations changing expression of MYG1 gene from the Replogle et al., Cell, 2022 RPE1 Essential Perturb-seq Gene Perturbation Signatures dataset. | |
| Rummagene Transcription Factor Associations 2026 | transcription factors regulating expression of MYG1 gene from the Rummagene Transcription Factor Associations 2026 dataset. | |
| RummaGEO Drug Perturbation Signatures | drug perturbations changing expression of MYG1 gene from the RummaGEO Drug Perturbation Signatures dataset. | |
| RummaGEO Gene Perturbation Signatures | gene perturbations changing expression of MYG1 gene from the RummaGEO Gene Perturbation Signatures dataset. | |
| Sci-Plex Drug Perturbation Signatures | drug perturbations changing expression of MYG1 gene from the Sci-Plex Drug Perturbation Signatures dataset. | |